InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Koopman Brian, Chief Financial Officer. Director active across 1 company, notably Utah Medical Products INC. In total, 6 disclosures have been recorded. History available since 27 October 2021. The latest transaction was filed on 4 September 2025 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
6 of 6 declarations
Koopman Brian is the Principal Financial Officer of Utah Medical Products Inc, a company specializing in medical devices. He is responsible for financial management and the company's financial strategy, playing a crucial role in its performance and growth.